BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, April 7, 2026
Home » Topics » Infection » Coronavirus

Coronavirus
Coronavirus RSS Feed RSS

Model of clamped vaccine antigen

CSL, University of Queensland partner with CEPI to bring COVID-19 vaccine to the clinic

June 8, 2020
By Tamra Sami
PERTH, Australia – Aussie biotech CSL Ltd. and the University of Queensland (UQ) have entered a development agreement with the Coalition for Epidemic Preparedness Innovations (CEPI) to accelerate  development, manufacture and distribution of a COVID-19 vaccine candidate developed by the University of Queensland.
Read More

Week in review for June 1-5, 2020: China’s pharma market to see slower growth, but increasing innovation

June 8, 2020
By Peter Winter
A quick look back at top stories.
Read More

Regulatory actions for June 8, 2020

June 8, 2020
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Algo, Arch, Cassi, Cytodyn, Enochian, Heat, Helsinn, Insmed, Kiniksa, Lupin, Sound, Taiho.
Read More

Other news to note for June 8, 2020

June 8, 2020
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: 4Bio, A2A Pharmaceuticals, Abcellera, Achilles, Advanced Bioscience Labs, Aerami, Aeterna Zentaris, Agex, Applied DNA, Cognition, Converge Bio, Emergent, Epivax, Evgen, Evotec, Find Therapeutics, Ideaya, Ilya, Intellia, Intravacc, Kyowa, Laxai, Microbiotica, Nimbus, Oncoceutics, Opiant, Oxford Biomedica, Pharmacyte, Sanofi, Sernova, Teneobio, Teva, Vectura, Versatope, Xbrane, Xphyto.
Read More

In the clinic for June 8, 2020

June 8, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aimmune, Alexion, Alpine Immune, Astellas, Astrazeneca, Axovant, Bavarian Nordic, Biocryst, Blueprint, Celldex, CSL, Deciphera, Fibrogen, Galapagos, Gilead, Janssen, Junshi, Kiniksa, Lilly, Neurana, Neurocrine, Neurorx, Precision Biosciences, Relief, Sarepta, Takeda.
Read More
Microscope image of SARS-CoV-2

Vayyar and Meditemi collaborate on robot that detects early COVID-19 in under 10 seconds

June 5, 2020
By David Ho
HONG KONG – Israel-based Vayyar Imaging Ltd. and Hong Kong-based Meditemi Co. Ltd. have teamed up to create a more intelligent care robot that provides a range of remote monitoring capabilities, including early detection of COVID-19 symptoms.
Read More

Regulatory front for June 5, 2020

June 5, 2020
The latest global regulatory news, changes and updates affecting medical devices and technologies.
Read More

Regulatory actions for June 5, 2020

June 5, 2020
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abiomed, Medtronic, Opti Medical Systems.
Read More
Hydroxychloroquine prescription bottle
‘Unequivocal evidence’

Study shows no clinical benefit with hydroxychloroquine in hospitalized COVID-19 patients

June 5, 2020
By Nuala Moran
LONDON – After all the controversy and a huge dose of hype, there is no clinical benefit from the use of hydroxychloroquine in patients admitted to the hospital with COVID-19, according to headline data from a large randomized trial of potential drugs for the infection currently running in the U.K.
Read More
Vaccine administration

Gavi sets up advance market commitment program for COVID-19 vaccines

June 5, 2020
By Nuala Moran
LONDON – The foundation stone of a system to ensure equitable access to COVID-19 vaccines was put in place by the global vaccines summit on June 4, with 12 donors pledging $567 million in seed money for an advance market commitment (AMC) program.
Read More
Previous 1 2 … 440 441 442 443 444 445 446 447 448 … 551 552 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 7, 2026.
  • Hengrui discovers new Nav1.8 blockers

    BioWorld Science
    Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
  • Cancer and blood cells

    Hematopoietic stem cell research points to leukemia’s early roots

    BioWorld Science
    Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
  • 3D illustration of antibodies

    Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis

    BioWorld Science
    Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for April 7, 2026
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing